Cargando…

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis

Unlike other biologic agents for rheumatoid arthritis (RA) that are administered at regular intervals even without flare, rituximab can be administered according to the timing of retreatment determined by the physician. Recently, there has been a tendency to prefer on-demand administration for disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji-Won, Jung, Ju-Yang, Shin, Kichul, Suh, Chang-Hee, Kim, Hyoun-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581042/ https://www.ncbi.nlm.nih.gov/pubmed/34778324 http://dx.doi.org/10.3389/fmed.2021.765535

Ejemplares similares

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study
por: Park, Jun Won, et al.
Publicado: (2022)

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
por: Jung, Ju-Yang, et al.
Publicado: (2023)

Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2019)

Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2022)

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry
por: Koh, Jung Hee, et al.
Publicado: (2022)

The Assessment of Muscle Mass and Function in Patients with Long-Standing Rheumatoid Arthritis
por: Yun, Hye-Won, et al.
Publicado: (2021)

Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
por: Kim, Min Jung, et al.
Publicado: (2022)

Anti-Inflammatory Effects of Low-Dose Glucocorticoids Compensate for Their Detrimental Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

Comparison of Retention Rates Between Tumor Necrosis Factor-α Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2021)

Biologic therapy for amyloid A amyloidosis secondary to rheumatoid arthritis treated with interleukin 6 therapy: Case report and review of literature
por: Jung, Ju-Yang, et al.
Publicado: (2021)

Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus
por: Kim, Ji-Won, et al.
Publicado: (2022)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
por: Shin, Kichul, et al.
Publicado: (2022)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis
por: Choi, Yong Jun, et al.
Publicado: (2017)

Rheumatoid Factor is a Marker of Disease Severity in Korean Rheumatoid Arthritis
por: Shin, Yoo-Seob, et al.
Publicado: (2005)

Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Jung, Ju-Yang, et al.
Publicado: (2020)

Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus
por: Bang, So-Young, et al.
Publicado: (2012)

Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
por: Kim, Se Hee, et al.
Publicado: (2021)

Bee venom acupuncture for rheumatoid arthritis: a systematic review of randomised clinical trials
por: Lee, Ju Ah, et al.
Publicado: (2014)

Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid arthritis treated with rituximab
por: Lim, Mie Jin, et al.
Publicado: (2023)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease
por: Kim, Ji-Won, et al.
Publicado: (2021)

Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database
por: Moon, Ki Won, et al.
Publicado: (2022)

Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria
por: Choi, Sang Tae, et al.
Publicado: (2018)

Bee venom acupuncture for rheumatoid arthritis: a systematic review protocol
por: Lee, Ju Ah, et al.
Publicado: (2014)

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review
por: Jung, Ju-Yang, et al.
Publicado: (2018)

Rituximab and its potential for the treatment of rheumatoid arthritis
por: Bryant, Adam, et al.
Publicado: (2006)

Targeted therapies in rheumatoid arthritis: Focus on rituximab
por: Teng, YKO, et al.
Publicado: (2007)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Tsiakalos, Aristotelis P, et al.
Publicado: (2008)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Update on the use of rituximab for intractable rheumatoid arthritis
por: Looney, R John
Publicado: (2009)

Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2020)

Reliability and Validity of the Korean Version of the Gout Impact Scale
por: Kim, Min Jung, et al.
Publicado: (2023)

The Risk of Osteoporotic Fractures According to the FRAX Model in Korean Patients with Rheumatoid Arthritis
por: Lee, Jae Ho, et al.
Publicado: (2014)

Therapeutic responses and prognosis in Korean adult-onset Still’s disease
por: Kim, Hyoun-Ah, et al.
Publicado: (2011)

Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations
por: Gilaberte Reyzabal, Sergio, et al.
Publicado: (2022)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
por: Kim, Hyun Jeong, et al.
Publicado: (2020)

Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score–Matched Analysis from the Korean College of Rheumatology Biologics Registry
por: Kim, Hyoun-Ah, et al.
Publicado: (2020)

Effectiveness and safety of bee venom pharmacopuncture for rheumatoid arthritis: a systematic review protocol
por: Sung, Won-Suk, et al.
Publicado: (2022)

Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
por: Sapart, Emillie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a044dvbninhgha796rf885o5nd